Policy / Pricing FDA Policy Tracker 2026: Psychedelics get a boost BioSpaceA year of significant policy change at the FDA brought momentum and scrutiny into the new year.Policy / PricingNeuroscienceRead full story pharminent April 20, 2026 (Last updated: April 20, 2026) BioSpace A year of significant policy change at the FDA brought momentum and scrutiny into the new year. Policy / PricingNeuroscienceRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: UK Knowledge Quarter welcomes Boehringer Ingelheim AI acceleratorNext: Beyond GLP-1Rs: emerging targets poised to gain share of obesity market Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
